Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

144.52
BATS BZX Real-Time Price
As of 12:18pm ET
 +2.01 / +1.41%
Today’s Change
124.16
Today|||52-Week Range
208.88
-24.24%
Year-to-Date
Baron Funds Comments on Alexion Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content
Pioneer climbs on oil output optimism
Apr 26 / FT.com - Paid Partner Content
Baron Funds Comments on Alexion Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close142.51
Today’s open143.59
Day’s range142.77 - 144.79
Volume32,779
Average volume (3 months)1,742,241
Market cap$31.9B
Dividend yield--
Data as of 12:18pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)+22.44%
Revenue growth (last year)+12.25%
P/E ratio221.5
Price/Sales16.57
Price/Book3.89

Competitors

 Today’s
change
Today’s
% change
SHPGShire+0.23+0.12%
ZTSZoetis Inc+0.90+1.94%
MYLMylan NV+0.99+2.40%
VRTXVertex Pharmaceutica...+2.11+2.50%
Data as of 12:19pm ET, 05/24/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts

Partner Offers

Search for Jobs